Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App





Abbott Presents Diagnostic Innovations to Enhance Patient Care at AACC 2022

By LabMedica International staff writers
Posted on 20 Jul 2022

Abbott Diagnostics (Lake Bluff, IL, USA) is offering one-on-one and group demonstrations of its latest diagnostic offerings at the 2022 AACC Clinical Lab Expo, including its next generation of Alinity systems that are designed to simplify diagnostics and help deliver results. More...

In addition, Abbott will be providing demonstrations of its GLP systems Track, AlinIQ Digital Health solutions, hematology, molecular, diabetes care and point of care solutions.

Visitors at the Abbott AACC 2022 booth can learn new ways to achieve measurably better healthcare performance with its personalized core diagnostics solutions consisting of Resourceful Advocates, Harmonized Systems and Intelligent Insights. During its product demonstrations at the event, visitors can explore Abbott's next generation of Alinity systems that uses technology to help redefine and improve operational productivity and confidence in the laboratory. The Alinity family is harmonized across key laboratory disciplines, streamlining critical interactions between individuals, systems and information, and enabling users to redefine performance in the laboratory and across the institution.

The Alinity family comprises the Alinity ci-series integrated clinical chemistry & immunoassay system combining up to four modules in multiple configurations to meet the laboratory's needs and maximize operational efficiency. The Alinity c is a compact clinical chemistry system that maximizes testing throughput with high-quality assays to deliver efficient and accurate performance. The ALINITY I is a compact immunoassay system that utilizes proven CHEMIFLEX chemiluminescent detection technology to provide greater confidence in results. The Alinity m is a fully integrated, automated, high-throughput molecular diagnostics analyzer with high-quality assays that delivers the next level of flexibility and efficiency to molecular labs.

At AACC 2022, Abbott is also demonstrating GLP systems Track that allows users to easily modify their track for future changes and maximize floor space while transforming the laboratory from 2D to 3D. GLP systems Track minimizes track implementation time, maximizes uptime with infinite redundancy, optimizes workflow, and decreases turnaround time system to meet the laboratory’s needs. In addition, Abbott will demonstrate how AlinIQ Always On services can help labs achieve operational efficiency and increase productivity by avoiding unexpected downtime. AlinIQ Always On Services utilizes Active Sense Technologies, Resourceful Advocates and Disciplined Processes to offer instrument health monitoring that enables laboratories to achieve operational efficiency and increase productivity.
 

Related Links:
Abbott Diagnostics 


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.